Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer

Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer: A Prospective Randomized Trial

The investigators think that trans-cervical endometrial tracer injection will cause more paraaortic sentinel lymph node detection. Also, this application is easy, cost-effective and safer than hysteroscopic method. Transtubal tumor spearing will not occur with this method.

Endometrial tracer injection will be performed by cervical or transcervical endometrial methods. Pelvic and para-aortic sentinel lymph node detection capacity will be assessed in this study.

Inclusion Criteria:

• Endometrial Cancer Patients
• Suitable patients for surgical staging

Exclusion Criteria:

• Patients who cannot undergo cervical or transcervical endometrial injection
• Pathology did not confirm endometrial cancer
• Sarcoma of the uterine corpus
• If a 90-day follow-up was not feasible